ALFA FinderBSE filing, NSE: LTM. Summary written from the filing by ALFA Finder's alert engine.
LTM Ltd: key numbers
- Share price
- ₹4,226.80
- Market cap
- ₹1,25,384 Cr
- Revenue (annual)
- ₹42,308 Cr
- Net profit (annual)
- ₹5,018 Cr
- P/E (TTM)
- 24.0×Sector 23.6×
- Promoter holding
- 69.01%+0.52% QoQ
- FII holding
- 6.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LTM Ltd
All →LTM Bags ₹950 Cr Order from Large global banking and financial services firm
LTM secured a two-year strategic engagement with a global BFSI firm worth up to USD 100 million (₹950 Cr). Scope covers technology consolidation across banking functions.
- Value
- ₹950.0 Cr
- From
- Large global banking and financial services firm (unnamed)
- Execution
- 2 years with option to extend for 1 additional year
LTM Capacity Expansion
LTM launched its BlueVerse Industrial AI Lab in Chennai on October 23, 2026. The co-innovation hub enables enterprises to scale AI across physical operations and intelligent products.
LTM Investor Presentation: Key Takeaways
LTM reported Q2 FY27 revenue of USD 1.24 billion, up 5.1% YoY in CC. The firm is pivoting to an AI-centric model with AI revenue reaching 13.4% of total sales.
LTM Other Announcement
This filing presents the quarterly shareholding pattern of LTM Ltd as required under SEBI regulations. It contains no material corporate events or transactions.
LTM Product Launch
LTM launches BlueVerse ValueMesh, an AI execution fabric to industrialize AI across Oracle transformations. The product unifies AI-native delivery, intelligent automation, and managed services for enterprise clients.
LTM Management Change
LTM Limited has appointed Anupam Kumar as a Non-Executive Non-Independent Director, effective October 16, 2026.
Other product launch announcements
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.